In our new sterile facility it is possible to realise development charges of 7 litres scheduled quantity as well as manufacturing campaigns with up to 3500 litres scheduled quantity. This applies both to terminal sterilised and aseptical products. In addition to that it is possible to expand existing production capacities as well as current production technologies by adding modular future extensions gradually and tailored to the needs. Future regulatory requirements have been anticipated and prepared during the planning of the new sterile production plant.
With no detoursUsing integrated pass-throughs and hatches in the new sterile production plant, materials can always be moved from one production stage to the next via the shortest route. All movements of materials and personnel within the sterile facility are minimised and organised in such a way that contaminations of the end product are eliminated from the outset.
Customised layout of the production plantWhat applies to the sterile production plant itself also applies to its connection to existing buildings including the organisation of all value added steps. Short ways, reduced interim storage and optimised material flow reflect the entire production layout of hameln pharma. At operational level they are completed by projects for improving value stream and increasing efficiency.